Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole

J. P. Rissing, C. Newman, W. L. Moore

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.

Original languageEnglish (US)
Pages (from-to)636-638
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume14
Issue number4
DOIs
StatePublished - Jan 1 1978

Fingerprint

Metronidazole
Aspartate Aminotransferases
NAD

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole. / Rissing, J. P.; Newman, C.; Moore, W. L.

In: Antimicrobial Agents and Chemotherapy, Vol. 14, No. 4, 01.01.1978, p. 636-638.

Research output: Contribution to journalArticle

@article{4e700fd6411343d6817d682ff1316b51,
title = "Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole",
abstract = "Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.",
author = "Rissing, {J. P.} and C. Newman and Moore, {W. L.}",
year = "1978",
month = "1",
day = "1",
doi = "10.1128/AAC.14.4.636",
language = "English (US)",
volume = "14",
pages = "636--638",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole

AU - Rissing, J. P.

AU - Newman, C.

AU - Moore, W. L.

PY - 1978/1/1

Y1 - 1978/1/1

N2 - Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.

AB - Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.

UR - http://www.scopus.com/inward/record.url?scp=0018084560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018084560&partnerID=8YFLogxK

U2 - 10.1128/AAC.14.4.636

DO - 10.1128/AAC.14.4.636

M3 - Article

C2 - 214030

AN - SCOPUS:0018084560

VL - 14

SP - 636

EP - 638

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

ER -